49
Participants
Start Date
May 31, 2012
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
MTX
"* Treatment A - 1 dose (4, 6, 8 or 10 tablets respectively to make up 10 mg, 15 mg, 20 mg or 25 mg MTX - per subject's dose group)~* Treatment B - SC injection using VIBEX MTX device into abdomen (VIBEX MTX device pre-filled with 10 mg, 15 mg, 20 mg or 25 mg MTX)~* Treatment C - SC injection using VIBEX MTX device into thigh (VIBEX MTX device pre-filled with 10 mg, 15 mg, 20 mg or 25 mg MTX)"
Altoona Center for Clinical Research, Duncansville
Lead Sponsor
Antares Pharma Inc.
INDUSTRY